Skip to main content
main-content

01.07.2014 | Urogenital | Ausgabe 7/2014

European Radiology 7/2014

Blood oxygenation level-dependent MR imaging as a predictor of therapeutic response to concurrent chemoradiotherapy in cervical cancer: a preliminary experience

Zeitschrift:
European Radiology > Ausgabe 7/2014
Autoren:
Chan Kyo Kim, Sung Yoon Park, Byung Kwan Park, Won Park, Seung Jae Huh

Abstract

Objectives

To investigate the value of blood oxygenation level-dependent (BOLD) magnetic resonance imaging (MRI) as a predictor of therapeutic response in cervical cancer patients undergoing concurrent chemoradiotherapy (CCRT).

Methods

Thirty consecutive patients with biopsy-proven cervical cancer were examined by BOLD MRI before (preTx) and after CCRT (postTx). The R2* value (s-1) was calculated in the tumour and normal myometrium for preTx and postTx studies. Final tumour responses, as determined by changes of tumour size or volume on MRI, were correlated with tumour R2* values at preTx.

Results

The mean R2* values of tumours at preTx (21.1) were significantly lower than those at postTx (39.4 s-1) (p < 0.001), while those of normal myometrium were similar between preTx and postTx (p = 0.363). At preTx, tumour R2* values showed significantly negative correlation with final tumour size response (p = 0.022, Spearman’s coefficient = -0.415). However, tumour R2* values at preTx were not associated with final tumour volume response (p = 0.069).

Conclusions

BOLD MRI at 3 T, as an imaging biomarker, may have the potential to evaluate therapeutic response in cervical cancers. The association between BOLD MRI findings and CCRT responses warrants further validation.

Key points

• Hypoxia in cervical cancer is an independent risk factor
• BOLD MRI reflect oxygenation status of tissue adjacent to perfused microvessels
• Pretreatment tumour R2* reveal negative correlation with final tumour size response
• Accurate oxygenation assessment in cervical cancer may help clinical decision making

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag als Mediziner*in

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Weitere Produktempfehlungen anzeigen
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 7/2014

European Radiology 7/2014 Zur Ausgabe
  1. Sie können e.Med Radiologie 14 Tage kostenlos testen (keine Print-Zeitschrift enthalten). Der Test läuft automatisch und formlos aus. Es kann nur einmal getestet werden.

Neu im Fachgebiet Radiologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Radiologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise